MedPath
FDA Approval

naproxen

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Cipla USA Inc.
DUNS: 078719707
Effective Date
January 18, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Naproxen(250 mg in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Cipla USA Inc.

078719707

Manufacturing Establishments2

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

InvaGen Pharmaceutical Inc

Cipla USA Inc.

Cipla USA Inc.

165104469

InvaGen Pharmaceuticals Inc.

Cipla USA Inc.

Cipla USA Inc.

080334903

Products3

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

naproxen

Product Details

NDC Product Code
69097-853
Application Number
ANDA091305
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
August 20, 2019
NaproxenActive
Code: 57Y76R9ATQClass: ACTIBQuantity: 250 mg in 1 1
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
POVIDONE, UNSPECIFIEDInactive
Code: FZ989GH94EClass: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRTClass: IACT

naproxen

Product Details

NDC Product Code
69097-855
Application Number
ANDA091305
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
August 20, 2019
NaproxenActive
Code: 57Y76R9ATQClass: ACTIBQuantity: 500 mg in 1 1
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
POVIDONE, UNSPECIFIEDInactive
Code: FZ989GH94EClass: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRTClass: IACT

naproxen

Product Details

NDC Product Code
69097-854
Application Number
ANDA091305
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
August 20, 2019
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
POVIDONE, UNSPECIFIEDInactive
Code: FZ989GH94EClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
FERRIC OXIDE REDInactive
Code: 1K09F3G675Class: IACT
NaproxenActive
Code: 57Y76R9ATQClass: ACTIBQuantity: 375 mg in 1 1
© Copyright 2025. All Rights Reserved by MedPath